← Explorer/Network

The role of erythropoietin in myocardial protection: potential mechanisms and applications

Schwartzenberg S, Ben-Shoshan J, Keren G +1 more2006Expert Review of Cardiovascular TherapyReview
10.1586/14779072.4.1.41PubMed
CardiovascularHematological

Abstract

The glycoprotein erythropoietin was originally discovered as a principal regulator that promotes the survival, proliferation and differentiation of erythroid progenitor cells. Despite potentially detrimental effects, such as increased blood pressure and hyperviscosity, recombinant human erythropoietin has been demonstrated to be a safe drug, as millions of anemia sufferers have received it over the last decade as a form of treatment. Recently, erythropoietin receptors have been discovered in a variety of tissues, including the cardiovascular system, and erythropoietin has been demonstrated to have a beneficial effect in congestive heart failure patients with anemia. The purpose of this review is to summarize the pleiotropic cardioprotective effects of erythropoietin in the cardiovascular system and to evaluate its potential role as a biomarker in these disorders.

Key Biomarkers

Blood pressureBlood viscosityErythropoietin

Symptom Clusters

AnemiaCongestive heart failure

Cited By (1)

  • Erythropoietin improves myocardial performance in doxorubicin-induced cardiomyopathyEuropean Heart Journal · 2006

References (7)

  • Effect of erythropoietin on exercise capacity in patients with moderate to severe chronic heart failureCirculation · 2003
  • Erythropoietin protects cardiac myocytes from hypoxia-induced apoptosis through an Akt-dependent pathwayBiochemical and Biophysical Research Communications · 2003
  • Hematopoietic factor erythropoietin fosters neuroprotection through novel signal; transduction cascadesJournal of Cerebral Blood Flow & Metabolism · 2002
  • Erythropoietin as a Retinal Angiogenic Factor in Proliferative Diabetic RetinopathyNew England Journal of Medicine · 2005
  • New avenues of exploration for erythropoietinJAMA · 2005

Related Papers

  • A Transcriptomic Fingerprint for Parkinson's Disease Found in Patients with Chronic Inflammatory Response Syndrome: Implications for Diagnosis, Treatment and PreventionMedical Research Archives · 2024 · 2 shared tags
  • Chronic Diarrhea and Weight Loss in an 18-month-old BoyPediatrics in Review · 2021 · 2 shared tags
  • Consequences of Aging on BoneAging and Disease · 2023 · 2 shared tags
  • Melanocortin 1 Receptor Deficiency in Hematopoietic Cells Promotes the Expansion of Inflammatory Leukocytes in Atherosclerotic MiceFrontiers in Immunology · 2021 · 2 shared tags
  • Altered Cytokine Response of Human Brain Endothelial Cells after Stimulation with Malaria Patient PlasmaCells · 2021 · 2 shared tags
  • A Novel Therapeutic Approach to Parkinson's Disease: Using Transcriptomics to Identify Unique Patterns of Gene Expression including 'Triple Positives,' Toll receptors, and Endotoxin ExposureMedical Research Archives · 2025 ·
A nonerythropoietic derivative of erythropoietin protects the myocardium from ischemia-reperfusion injury
Proceedings of the National Academy of Sciences · 2005
  • Erythropoietin and VEGF exhibit equal angiogenic potentialMicrovascular Research · 2002
  • 2 shared tags